Editorials
‘Multimorbidity’: an acceptable term for patients or time for a rebrand?
Carolyn Chew-Graham, Liam O’Toole, Jane Taylor and Chris Salisbury
British Journal of General Practice 2019; 69 (685): 372-373. DOI: https://doi.org/10.3399/bjgp19X704681
Carolyn Chew-Graham
Research Institute, Primary Care & Health Sciences, Keele University, Keele.
GPRoles: NHS Manchester, Professor of General Practice Research
Liam O’Toole
CEO of Versus Arthritis and Chairman of the Taskforce on Multiple Long-Term Conditions, London.
Jane Taylor
Taskforce on Multiple Long-Term Conditions; Chair of the Patient Insight Group at Versus Arthritis and a member of NIHR INVOLVE advisory group, London.
Roles: Expert by Experience
Chris Salisbury
Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol.
Roles: Professor of Primary Health Care
In this issue
‘Multimorbidity’: an acceptable term for patients or time for a rebrand?
Carolyn Chew-Graham, Liam O’Toole, Jane Taylor, Chris Salisbury
British Journal of General Practice 2019; 69 (685): 372-373. DOI: 10.3399/bjgp19X704681
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals